About
Aprovix develops Qvintip®, a clinically validated, single-use self-sampling device that enables at-home HPV testing with clinical accuracy comparable to clinician-collected samples, aimed at increasing access to cervical cancer screening.
Explore Aprovix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.